20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LEVETIRACETAM (PROCESS B), with a corresponding US DMF Number 30185.
Remarkably, this DMF maintains an Active status since its submission on January 08, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 30, 2016, and payment made on January 29, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II